Myeloproliferative neoplasms trials in China
30 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingTrial-stage medicine
Asciminib Roll-over Study
- Where
- Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin, Wuhan, Xian, Zhengzhou
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522EU 2023-507557-16-00Registry updated 2026-11-09
No phaseNot yet recruitingResearch participation
A Multicenter, Prospective, Observational Study of Jaktinib in Newly Diagnosed Myelofibrosis
- Where
- Nantong
- Age
- 18 years and over
- People
- 80
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT07925632Registry updated 2026-11-09
No phaseNot yet recruitingResearch participation
Jaktinib in Ruxolitinib-Treatment Failure Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study
- Where
- Nantong
- Age
- 18 years and over
- People
- 80
- Run by
- Affiliated Hospital of Nantong University
See details and how to joinNCT07925671Registry updated 2026-11-09
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Beijing, Changchun, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanchang, Nanjing, Nantong, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Yantai
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727EU 2025-523555-66-00Registry updated 2026-11-06
Phase 1RecruitingTrial-stage medicine
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Where
- Beijing, Hangzhou, Tianjin
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06150157EU 2023-505584-36-00Registry updated 2026-11-04
Phase 1/2RecruitingTrial-stage medicine
An Exploratory Study on the Use of Gecacitinib in Patients With Myeloid Malignancies and Myelofibrosis During the Peri-transplant Period Following Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Shanghai
- Age
- 18 years and over
- People
- 10
- Run by
- Ruijin Hospital
See details and how to joinNCT07883382Registry updated 2026-10-28
Phase 1/2RecruitingTrial-stage medicine
A Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Lanzhou, Nanchang, Shenzhen, Suzhou, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130EU 2023-508881-14-00Registry updated 2026-09-14
No phaseRecruitingResearch participation
Haplo-HSCT for Myelofibrosis
- Where
- Beijing
- People
- 39
- Run by
- Peking University People's Hospital
See details and how to joinNCT06674382Registry updated 2026-09-14
Phase 1RecruitingTrial-stage medicine
Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis
- Where
- Zhengzhou
- Age
- 18 days and over
- People
- 20
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07802405Registry updated 2026-09-03
Phase 1RecruitingTrial-stage medicine
Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 90
- Run by
- BeBetter Med Inc
See details and how to joinNCT07012109Registry updated 2026-08-18
Phase 2RecruitingTrial-stage medicine
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
- Where
- Tianjin
- Age
- 18 years and over
- People
- 60
- Run by
- Chengdu Zenitar Biomedical Technology Co., Ltd
See details and how to joinNCT07232290Registry updated 2026-08-14
Phase 3RecruitingTrial-stage medicine
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
- Where
- Chengdu, Tianjin
- Age
- 18 years to 80 years
- People
- 105
- Run by
- Chengdu Zenitar Biomedical Technology Co., Ltd
See details and how to joinNCT07317700Registry updated 2026-08-13
Phase 2RecruitingTrial-stage medicine
A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk Myelofibrosis
- Where
- Chengdu, Tianjin
- Age
- 18 years to 80 years
- People
- 64
- Run by
- Chengdu Zenitar Biomedical Technology Co., Ltd
See details and how to joinNCT07443306Registry updated 2026-08-13
Phase 2RecruitingTrial-stage medicine
A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis
- Where
- Cangzhou, Changchun, Changzhi, Chengde, Chengdu, Fuzhou, Guangzhou, Hangzhou, Hefei, Nanjin, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Tianjin, Ürümqi, Wuhan, Xi’an, Xingtai, Zhengzhou, Zhuzhou
- Age
- 18 years and over
- People
- 51
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07551427Registry updated 2026-07-15
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Tianjin
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060Registry updated 2026-07-01
No phaseRecruitingTrial-stage medicine
A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV
- Where
- Beijing
- Age
- 18 years and over
- People
- 30
- Run by
- Duan Minghui
See details and how to joinNCT07445893Registry updated 2026-06-24
Phase 2/3Not yet recruitingTrial-stage medicine
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
- Where
- Guangzhou
- Age
- 18 years to 65 years
- People
- 196
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07539779Registry updated 2026-04-20
Phase 1RecruitingTrial-stage medicine
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects
- Where
- Jinan, Luoyang
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07480824Registry updated 2026-04-06
No phaseRecruitingResearch participation
National Longitudinal Cohort of Hematological Diseases
- Where
- Tianjin
- People
- 2,300
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199Registry updated 2026-02-12
No phaseRecruitingResearch participation
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 57
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06164561Registry updated 2026-02-04
Phase 1/2RecruitingTrial-stage medicine
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
- Where
- Cangzhou, Changchun, Changzhi, Chengde, Guangzhou, Harbin, Hohhot, Nanning, Shanghai, Tai’an, Tangshan, Tianjin, Ürümqi, Wuhan, Wuxi, Xi'an, Xingtai, Zhengzhou
- Age
- 18 years and over
- People
- 92
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06122831Registry updated 2025-12-08
Phase 2RecruitingTrial-stage medicine
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
- Where
- Beijing, Fujian, Guangzhou, Harbin, Henan, Shanghai, Zhejiang
- Age
- 18 years and over
- People
- 27
- Run by
- Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT06552429Registry updated 2025-11-17
Phase 1RecruitingTrial-stage medicine
A Study of GLB-001 in Patients With Myeloid Malignancies
- Where
- Beijing, Chongqing, Hangzhou, Hefei, Nanchang, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 108
- Run by
- Hangzhou GluBio Pharmaceutical Co., Ltd.
See details and how to joinNCT06378437Registry updated 2025-08-19
Phase 1RecruitingTrial-stage medicine
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
- Where
- Hangzhou, Nanchang, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 108
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06752746Registry updated 2025-05-11
No phaseRecruitingTrial-stage medicine
Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
- Where
- Chengdu
- Age
- 1 year to 3 years
- People
- 90
- Run by
- West China Second University Hospital
See details and how to joinNCT06881056Registry updated 2025-03-18
All Myeloproliferative neoplasms trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.